Multi-scale computational modeling towards efficacy in radiopharmaceutical therapies while minimizing side effects: Modeling of amino acid infusion
Table 3
Impact of amino acid administration on RPT Efficacy. Kidney and salivary gland organs are individually designated as organs-at-risk, determining the maximum safe injected activity. Subsequently, the absorbed dose to tumors is computed. Left column indicates the maximum possible activity that can be injected and the tumor absorbed dose when the kidney is the organ at risk, with and without amino acid administration. Right column indicates the maximum possible activity that can be injected and the tumor absorbed dose when the salivary gland is the organ at risk, with and without amino acid administration.